alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report on Form 10-Q of MediStaff Corporation
(the “Company”) for the quarter ended September 30, 2010, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), John Wang,
Chief Executive Officer and Chief Financial Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. §78m or §78o(d)); and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:
      November 15, 2010
                By:
                /s/ John WangJohn
      Wang
                  Chief
      Executive Officer and Chief Financial Officer
                  (Principal
      Executive Officer and Principal Financial
  Officer)





This
certification accompanies each Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.





A signed
original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
PIONEER TAX-FREE INCOME FUND
                                 60 State Street
                                Boston, MA 02109


                                                          May 5, 1997

VIA ELECTRONIC TRANSMISSION

Securities and Exchange Commission
File Desk
Judiciary Plaza
450 Fifth Street, NW
Washington, DC  20549

Re:           Pioneer Tax-Free Income Fund (the "Fund")
              File Nos. 2-57653 and 811-2704
              CIK No. 0000202679

Ladies and Gentlemen:

              Pursuant to Rule 497(j)  under the  Securities  Act of 1933,  this
letter  certifies that the  Prospectus  and Statement of Additional  Information
that would have been  required to be filed under  paragraph (c) of Rule 497 does
not differ from that contained in the Post-Effective Amendment,  dated April 30,
1997  and  that  the  text of the  Post  -Effective  Amendment  has  been  filed
electronically, Accession No.
0000202679-97-000007.

              If you have any  questions or comments  concerning  the  enclosed,
please contact me at (617) 742-7825 (collect).

                                                 Very truly yours,

                                                      /s/ Patricia M. Ballard
                                                      Patricia M. Ballard
                                                      Paralegal



     cc:      Mses. Rajotte/Alves
              Mr. Joseph P. Barri, Esq.
              Mr. Mark P. Goshko, Esq.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. EC10-27-000]

Take notice that on January 11, 2010, Empire Generating Co, LLC filed a clarification to its December 01, 2009, section 203 application, in response to the Commission's request.

Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211, 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed on or before the comment date. Anyone filing a motion to intervene or protest must serve a copy of that document on the Applicant and all the parties in this proceeding.

                    The Commission encourages electronic submission of protests and interventions in lieu of paper using the “eFiling” link at                     *http://www.ferc.gov.*                     Persons unable to file electronically should submit an original and 14 copies of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426.                

                    This filing is accessible on-line at                     *http://www.ferc.gov,*                     using the “eLibrary” link and is available for review in the Commission's Public Reference Room in Washington, DC. There is an “eSubscription” link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail                     *FERCOnlineSupport@ferc.gov,*                     or call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.                

*Comment Date:*                     5 p.m. Eastern Time on January 21, 2010.                

Kimberly D. Bose,

Secretary.

[FR Doc. 2010-1010 Filed 1-20-10; 8:45 am]

BILLING CODE 6717-01-P
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: In re TIC Philly Lansdale 2, LLC, TIC Philly Lansdale 3, LLC, TIC 

Philly Lansdale 4, LLC, TIC Philly Lansdale 5, LLC, TIC Philly 

Lansdale 6, LLC, TIC Philly Lansdale 7, LLC, TIC Philly Lansdale 8, 

LLC, TIC Philly Lansdale 9, LLC, TIC Philly Lansdale 10, LLC, TIC 

Philly Lansdale 11, LLC, TIC Philly Lansdale 13, LLC, TIC Philly 

Lansdale 14, LLC, TIC Philly Lansdale 16, LLC, TIC Philly Lansdale 

18, LLC, TIC Philly Lansdale 19, LLC, TIC Philly Lansdale 20, LLC, 

TIC Philly Lansdale 21, LLC, TIC Philly Lansdale 23, LLC, TIC 

Philly Lansdale 24, LLC, TIC Philly Lansdale 25, LLC, TIC Philly 

Lansdale 27, LLC, TIC Philly Lansdale 29, LLC, TIC Philly Lansdale 

30, LLC, TIC Philly Lansdale 31, LLC, TIC Philly Lansdale 32, LLC, 

TIC Philly Lansdale 33, LLC, and Wayne Mar, d/b/a TIC Philly 

Lansdale H

Appellate case number: 01-22-00192-CV

Trial court case number: 2021-46723

Trial court: 151st District Court of Harris County

On March 15, 2022, relators filed a Request for Temporary Relief, asking this Court to 

stay all trial court proceedings in Cause No. 2021-46723, TIC Philly Lansdale 1, LLC, et al. v. 

Moody National Philly Lansdale S, LLC, et al., in the 151st District Court of Harris County, 

Texas. Relators’ motion for temporary relief is denied.

It is so ORDERED.

Judge’s signature: ___________/s/ Julie Countiss__________

Acting individually 

Date: March 18, 2022
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-KSB
FOR THE FISCAL YEAR ENDED DECEMBER 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                          88,221
<SECURITIES>                                         0
<RECEIVABLES>                                3,402,157
<ALLOWANCES>                                   190,000
<INVENTORY>                                  4,809,687
<CURRENT-ASSETS>                             8,562,910
<PP&E>                                       5,398,573
<DEPRECIATION>                               3,337,129
<TOTAL-ASSETS>                              11,340,031
<CURRENT-LIABILITIES>                        5,334,737
<BONDS>                                      5,419,159
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        29,500
<OTHER-SE>                                     556,635
<TOTAL-LIABILITY-AND-EQUITY>                11,340,031
<SALES>                                     22,687,765
<TOTAL-REVENUES>                            22,687,765
<CGS>                                       15,587,552
<TOTAL-COSTS>                               15,587,552
<OTHER-EXPENSES>                             5,800,581
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             546,678
<INCOME-PRETAX>                                752,954
<INCOME-TAX>                                  (65,000)
<INCOME-CONTINUING>                            817,954
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   817,954
<EPS-PRIMARY>                                     0.28
<EPS-DILUTED>                                        0


</TABLE>
EXHIBIT 32  CERTIFICATION Pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002)  In connection with the Quarterly Report on Form 10-Q of Affinity Mediaworks Corp. (the "Company") for the period ended July 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Yulia Nesterchuk, hereby certifies, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:  (1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   Date: September 14, 2008       BY: /s/ Yulia Nesterchuk -------------------------------------------------- Yulia Nesterchuk President, Principal Executive Officer, Treasurer, Principal Financial Officer, Principal Accounting Officer and sole member of the Board of Directors.   This certification accompanies each Report pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.18 of the Securities Exchange Act of 1934, as amended.  A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5770 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 5770

  To direct the Attorney General to amend certain regulations so that 
  practitioners may administer not more than 3 days' medication to a 
person at one time when administering narcotic drugs for the purpose of 
                  relieving acute withdrawal symptoms.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 10, 2018

   Mr. Ruiz introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
  To direct the Attorney General to amend certain regulations so that 
  practitioners may administer not more than 3 days' medication to a 
person at one time when administering narcotic drugs for the purpose of 
                  relieving acute withdrawal symptoms.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Easy Medication Access and Treatment 
for Opioid Addiction Act'' or the ``Easy MAT for Opioid Addiction 
Act''.

SEC. 2. ADMINISTRATION OF NARCOTIC DRUGS FOR THE PURPOSE OF RELIEVING 
              ACUTE WITHDRAWAL SYMPTOMS.

    Not later than 180 days after the date of enactment of this Act, 
the Attorney General shall revise section 1306.07(b) of title 21, Code 
of Federal Regulations, so that practitioners are allowed to administer 
not more than a three-day supply of medication to one person or for one 
person's use at one time.
                                 <all>
```
* Pursuant to 5 TH C IR

. R. 47.5, the court has determined th a t

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 98-10744

Summary Calendar

Doris Stevenson, et al. Plaintiff-Appellee,

versus

Rochdale Investment Defendant-Appellant.

Management, Inc.

Appeal from the United States District Court

for the Nortern District of Texas

(3:97-CV-1544-T)

February 18, 1999

Before HIGGINBOTHAM, JONES and DENNIS, Circuit Judges.

PER CURIAM: *

Rochd a le filed an interlocutory appeal from the district

court’s denial of its motion to stay and compel arbitration. The

plaintiffs argue that this court lacks jurisdiction over this

appeal or, in the alternative, that the district court’s denial

should be affirmed.

Jurisdiction over Rochdale’s appeal f rom an order denying a

motion to stay proc eedings and compel arbitration is proper

pursuant to 9 U.S.C. § 16(a). A trial court's finding that a

party has waived its right to arbit ration is subject to de novo

review, but the factual findings underlying that conclusion may not2

be overturned unless clearly erroneous. F rye v. Paine, Webber,

Jackson & Curtis, Inc.

, 877 F .2d 396, 398 (5th Cir. 1989), c ert.

denied , 494 U.S. 1016 (1990).

Although there is a presumption against waiver, waiver may be

found when the party seeking arbitration substantially invokes the

judicial process to the detriment or prejudice of the other party.

Walker v. J.C. Bradford & Co. , 938 F.2d 575, 577 (5th Cir. 1991);

see also Price v. Drexel Burnham Lambert, Inc

., 791 F.2d 1156 (5th

Cir. 1986). The district court’s finding of prejudice to the

plaintiffs is not clearly erroneous. In addition, Rochdale’s

proffered justification for its belated motion to compel

arbitration, that it was not aware that the plaintiffs intended to

argue that the Investment Advisory Agreements were accepted by

Rochdale, is unconvincing given the facts of this case.

The district court’s denial of Rochdale’s motion to stay and

compel arbitration is AFFIRMED.
IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF FLORIDA

PANAMA CITY DIVISION

BRADLEY ROBERT LAMB,

Plaintiff,

vs. CASE NO. 5:11cv85/RS-GRJ

RICK SCOTT and EDWIN G.

BUSS,

Defendants.

_________________________________/

ORDER

Before me are the Magistrate Judge’s Report and Recommendation (Doc. 8) and 

Plaintiff’s Objections To The Report And Recommendation (Doc. 9). I have considered

Plaintiff’s objections de novo.

IT IS ORDERED:

1. The Magistrate Judge’s Report and Recommendation is approved and is

incorporated in this Order.

2. The Complaint (Doc. 1) is dismissed pursuant to 28 U.S.C. §1915A for

failure to state a claim upon which relief may be granted.

3. Plaintiff’s First Amended Complaint (Doc 10) is dismissed because

Plaintiff has not complied with the requirements of Fed. R. Civ. P.

15(a)(2).

4. Plaintiff’s Motion To Proceed In Forma Pauperis (Doc. 11) is denied as

moot. Plaintiff has already paid the filing fee required for this case and

has not filed a notice of appeal.

Case 5:11-cv-00085-RS-GRJ Document 12 Filed 04/25/11 Page 1 of 2
 

 ORDERED on April 25, 2011.

/S/ Richard Smoak 

RICHARD SMOAK

UNITED STATES DISTRICT JUDGE

Case 5:11-cv-00085-RS-GRJ Document 12 Filed 04/25/11 Page 2 of 2
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6059 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 6059

 To designate the facility of the United States Postal Service located 
at 51 Willow Street in Lynn, Massachusetts, as the ``Thomas P. Costin, 
                      Jr. Post Office Building''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              June 8, 2018

 Mr. Moulton introduced the following bill; which was referred to the 
              Committee on Oversight and Government Reform

_______________________________________________________________________

                                 A BILL

 
 To designate the facility of the United States Postal Service located 
at 51 Willow Street in Lynn, Massachusetts, as the ``Thomas P. Costin, 
                      Jr. Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. THOMAS P. COSTIN, JR. POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 51 Willow Street in Lynn, Massachusetts, shall be known and 
designated as the ``Thomas P. Costin, Jr. Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Thomas P. 
Costin, Jr. Post Office Building''.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; “Biodefense and Emerging Infectious Diseases Research Opportunities”.                    

*Date:*                         March 5, 2008.                    

*Time:*                         12 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room #3129, Bethesda, MD 20817, (Telephone Conference Call).                    

*Contact Person:*                         Eleazar Cohen, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3129, 6700 B Rockledge Drive, Bethesda, MD 20892, 301-435-3564,                         *ec17w@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: February 4, 2008.

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-579  Filed 2-8-08; 8:45 am]

BILLING CODE 4140-01-M
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AT DECEMBER 31, 1998 AND THE STATEMENT OF OPERATIONS FOR THE YEAR ENDED
DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1998
<CASH>                                       3,140,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,172,000
<PP&E>                                          23,000
<DEPRECIATION>                                  11,000
<TOTAL-ASSETS>                               3,238,000
<CURRENT-LIABILITIES>                           30,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        21,000
<OTHER-SE>                                   3,187,000
<TOTAL-LIABILITY-AND-EQUITY>                 3,238,000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,201,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,000
<INCOME-PRETAX>                            (1,028,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,028,000)
<EPS-PRIMARY>                                   (0.59)
<EPS-DILUTED>                                   (0.59)
        

</TABLE>